3/8 Late treatment study
A single-center retrospective cohort study of Covid-19 medications: Remdesivir, Favipiravir, Methylprednisolone, Dexamethasone, and Interferon β1a and their combinations
et al., medRxiv, doi:10.1101/2021.03.05.21251351 (Preprint)
Retrospective 324 hospitalized patients in Iran reporting on the use Remdesivir, Favipiravir, Methylprednisolone, Dexamethasone, and Interferon β1a and their combinations. There is no control group in this study, however authors suggest that Interferon β1a, corticosteroids, and remdesivir may not have a significant effect on mortality of hospitalization time.
Fateh et al., 3/8/2021, retrospective, Iran, Middle East, preprint, 7 authors.
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.